Ingalls & Snyder LLC Portfolio Holdings

Ingalls & Snyder LLC

  • $2.82 Billion
  • Q2 2025

Ingalls & Snyder LLC has filed its 13F form on July 31, 2025 for Q2 2025 where it was disclosed a total value porftolio of $2.82 Billion distributed in 466 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Corcept Therapeutics Inc with a value of $567M, Microsoft Corp with a value of $102M, Williams Companies, Inc. with a value of $89.1M, Berkshire Hathaway Inc Class B with a value of $86M, and Exxon Mobil Corp with a value of $83.8M.

Examining the 13F form we can see an decrease of $222M in the current position value, from $3.04B to 2.82B.

Ingalls & Snyder LLC is based out at New York, NY

Below you can find more details about Ingalls & Snyder LLC portfolio as well as his latest detailed transactions.

Portfolio value $2.82 Billion
Healthcare: $769 Million
Technology: $352 Million
Energy: $348 Million
Financial Services: $347 Million
Industrials: $215 Million
Communication Services: $185 Million
Consumer Cyclical: $170 Million
Consumer Defensive: $115 Million
Other: $252 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$0
$1.54 Million 0.05% of portfolio
29,116
Q2 2025 Reduced 0.68%
Omeros Corp
-
$1.48 Million 0.05% of portfolio
-
Q1 2025 Reduced 1.03%
$0
$1.22 Million 0.04% of portfolio
12,334
Q2 2025 Reduced 1.0%
$0
$1.19 Million 0.04% of portfolio
8,816
Q2 2025 Reduced 1.64%
$26.8B
$1.1 Million 0.04% of portfolio
10,755
Q1 2025 Reduced 0.51%
$0
$1 Million 0.04% of portfolio
18,440
Q2 2025 Reduced 0.67%
$1.5B
$1.1 Million 0.04% of portfolio
129,600
Q2 2025 Added 59.02%
$139B
$1.13 Million 0.04% of portfolio
9,152
Q2 2025 Reduced 0.03%
$0
$1.13 Million 0.04% of portfolio
4,548
Q2 2025 Reduced 10.35%
$29.2B
$1.17 Million 0.04% of portfolio
22,521
Q2 2025 Reduced 0.07%
$17.1B
$1.01 Million 0.04% of portfolio
18,048
Q2 2025 Reduced 0.34%
$187B
$1 Million 0.04% of portfolio
2,477
Q2 2025 Added 36.55%
$86B
$1.09 Million 0.04% of portfolio
15,823
Q2 2025 Reduced 5.24%
$95.8B
$1.13 Million 0.04% of portfolio
9,609
Q2 2025 Reduced 9.47%
$57.7B
$1.08 Million 0.04% of portfolio
9,012
Q2 2025 Reduced 0.11%
$4.64B
$1.02 Million 0.04% of portfolio
32,440
Q1 2025 Added 10.57%
$14.5B
$1.03 Million 0.04% of portfolio
3,028
Q2 2025 Reduced 14.8%
Arista Networks Inc
-
$1.15 Million 0.04% of portfolio
-
Q4 2024 New
$63.5B
$1.16 Million 0.04% of portfolio
11,458
Q2 2025 Reduced 0.17%
$79.8M
$1.05 Million 0.04% of portfolio
2,135,125
Q2 2023 Reduced 1.56%
$50.7B
$1.06 Million 0.04% of portfolio
21,815
Q2 2025 Added 3.81%
$302B
$1.01 Million 0.04% of portfolio
12,569
Q2 2025 Reduced 0.08%
$0
$904,000 0.03% of portfolio
2,496
Q2 2025 Added 24.43%
$245B
$954,000 0.03% of portfolio
3,057
Q2 2025 Reduced 70.31%
$58.4B
$948,000 0.03% of portfolio
22,058
Q1 2025 Reduced 8.31%
$20.5B
$847,000 0.03% of portfolio
23,620
Q2 2025 Added 70.96%
$17.2B
$892,000 0.03% of portfolio
22,123
Q2 2025 Reduced 0.52%
$96.8B
$774,000 0.03% of portfolio
7,359
Q2 2025 Reduced 9.81%
$258B
$789,000 0.03% of portfolio
11,200
Q2 2025 Reduced 0.34%
$121B
$770,000 0.03% of portfolio
15,945
Q1 2025 Reduced 3.04%
$118B
$836,000 0.03% of portfolio
320
Q1 2025 Reduced 13.51%
$76.4B
$890,000 0.03% of portfolio
5,790
Q2 2025 Reduced 1.19%
$0
$789,000 0.03% of portfolio
31,129
Q2 2024 Reduced 10.24%
$5.63B
$747,000 0.03% of portfolio
3,950
Q1 2025 Reduced 12.22%
$0
$834,000 0.03% of portfolio
3,836
Q2 2025 Reduced 34.96%
$14.5B
$718,000 0.03% of portfolio
78,108
Q2 2025 New
$33.9B
$960,000 0.03% of portfolio
12,932
Q2 2025 Reduced 0.47%
$18B
$945,000 0.03% of portfolio
28,800
Q1 2025 Reduced 14.54%
$61.1B
$739,000 0.03% of portfolio
2,310
Q2 2025 Reduced 0.77%
Durect Corp
-
$857,000 0.03% of portfolio
-
Q2 2025 Added 1.1%
$44.8B
$756,000 0.03% of portfolio
25,236
Q2 2025 Reduced 0.32%
$16.6B
$752,000 0.03% of portfolio
13,419
Q1 2025 Reduced 0.58%
$55B
$945,000 0.03% of portfolio
12,915
Q2 2025 Added 4.63%
$4.81B
$802,000 0.03% of portfolio
26,637
Q2 2025 Reduced 0.02%
Gsk PLC
-
$730,000 0.03% of portfolio
-
Q2 2025 Reduced 0.83%
$1.55B
$778,000 0.03% of portfolio
183,900
Q2 2025 Added 1.1%
$1.89B
$800,000 0.03% of portfolio
76,789
Q2 2025 Reduced 14.58%
$0
$707,000 0.03% of portfolio
74,850
Q1 2025 Reduced 5.67%
$55.6B
$880,000 0.03% of portfolio
16,724
Q2 2025 Reduced 4.87%

Summary

  • Portfolio
  • No. of Stocks 466
  • Current Value $2.82 Billion
  • Prior Value $3.04 Billion
  • Filing
  • Period Q2 2025
  • Filing Date July 31, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 33 stocks
  • Additional Purchases 102 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 197 stocks
Track This Portfolio

Track Ingalls & Snyder LLC Portfolio

Follow Ingalls & Snyder LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ingalls & Snyder LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email